Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMUB8WN)

Drug Name

Aerovant Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Asthma	CA23	Phase 2a	[1]

Cross-matching ID

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Interleukin 4 receptor alpha (IL4R)	TTDWHC3	IL4RA_HUMAN	Antagonist	[2]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Interleukin 4 receptor alpha (IL4R)	DTT	IL4R	8.599	8.06	6.589	7.357

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Asthma

ICD Disease Classification

CA23

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Interleukin 4 receptor alpha (IL4R)	DTT	IL4R	1.48E-08	0.76	3.74

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Emerging drugs for asthma. Expert Opin Emerg Drugs. 2008 Dec;13(4):643-53.
2	Aerovance starts trial of Aerovant for uncontrolled asthma. Aerovance. March 3, 2009.